RecruitingNot ApplicableNCT06778070
National Program to Overcome Pelvic Pain studY (POPPY)
Sponsor
University of California, San Francisco
Enrollment
220 participants
Start Date
May 12, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
A randomized, parallel-group, investigator-blinded, comparative effectiveness trial of a fully remote, videoconference-based pelvic floor yoga program versus a physical conditioning program for women with chronic pelvic pain syndrome.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria5
- Women (individuals reporting female sex assigned at birth who self-identify as women or non-binary) aged 18 years or older
- Report chronic or recurrent pain in the pelvis (between or below the anterior iliac crests) for at least 6 months
- Report at least moderate pain intensity based on a screening pain log
- Report prior clinical evaluation of their pelvic pain by a healthcare professional including at least a superficial pelvic exam
- Willing to refrain from initiating new clinical treatments that may affect their pain during the study period
Exclusion Criteria12
- Report pelvic pain occurring exclusively with menses or exclusively during sexual intercourse (although candidates with at least some pain between menses or intercourse are still eligible)
- Participation in organized yoga classes or muscle strengthening programs (e.g., Pilates) in the past 4 weeks, or any prior yoga therapy specifically directed at pelvic pain
- Lacking technical requirements to complete intervention classes by video, including no access to broadband internet or a Zoom-compatible device larger than a smartphone \[display screen at least 7 inches in diagonal\] (although the study team may loan devices to participants from underrepresented backgrounds)
- Currently pregnant (by self-report or screening test), pregnant within the past 12 weeks, or planning pregnancy during the study period
- Diagnosed with an alternate, reversible cause of pelvic pain that is unlikely to respond to yoga and requires another treatment modality (e.g., current pelvic infection or a gynecologic dermatosis)
- Surgery or irradiation to the genital or pelvic structures within the past 12 weeks, or anticipating upcoming surgery or irradiation to these structures during the study period
- Initiation, dose escalation, or weaning of pharmacologic agents that may affect pelvic pain severity in the past 4 weeks, such as analgesics, antidepressants, or anticonvulsants-(however, women on stable doses of these medications for at least 4 weeks will still be eligible)
- Use of formal psychological therapies specifically for pelvic pain (e.g., systematic desensitization, cognitive therapy, relaxation therapy) within 4 weeks of screening, or plans to engage in these therapies during the study period
- Unable to walk up a flight of stairs or at least 2 blocks on level ground (i.e., functional capacity < 4 METs), or unable to get up from a supine to a standing position without assistance
- Participation in another interventional study that might interfere with or confound study procedures, or known conflict with multiple upcoming study intervention class dates
- Inability to understand the informed consent form or fill out questionnaires or complete study interviews
- Any other serious physical or mental issue that, in the opinion of the investigators, would interfere with study participation (e.g., advanced dementia, uncontrolled substance use or serious mental illness, life expectancy <6 months)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERPelvic floor yoga
Pelvic floor yoga
OTHERPhysical conditioning
Physical conditioning
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06778070
Related Trials
Impact of Pelvic Pain Podcast
NCT075688341 location
Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)
NCT068859317 locations
Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
NCT062085141 location
Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
NCT074948641 location
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
NCT061680583 locations